Open AccessEfficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study
Author(s) -
Matteo Megna,
Luigi Fornaro,
Luca Potestio,
Maria Antonietta Luciano,
Mariateresa Nocerino,
Mario Delfino,
Maria Guarino,
Gabriella Fabbrocini,
Elisa Camela
Publication year - 2022
Publication title -
psoriasis targets and therapy
Language(s) - English
Resource type - Journals
ISSN - 2230-326X
DOI - 10.2147/ptt.s365493
Subject(s) - biosimilar , medicine , etanercept , psoriasis , adalimumab , psoriatic arthritis , adverse effect , psoriasis area and severity index , infliximab , observational study , dermatology , tumor necrosis factor alpha
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom